These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30957185)
21. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway. Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892 [TBL] [Abstract][Full Text] [Related]
22. Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway. Gai H; Zhou F; Zhang Y; Ai J; Zhan J; You Y; Huang W J Food Sci; 2020 Nov; 85(11):4050-4060. PubMed ID: 33037652 [TBL] [Abstract][Full Text] [Related]
23. Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways. Shen B; Feng H; Cheng J; Li Z; Jin M; Zhao L; Wang Q; Qin H; Liu G J Cell Mol Med; 2020 May; 24(9):5097-5108. PubMed ID: 32293113 [TBL] [Abstract][Full Text] [Related]
25. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Liu Y; Xu W; Zhai T; You J; Chen Y Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535 [TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells. Zhou X; Wang LL; Tang WJ; Tang B J Ethnopharmacol; 2021 Mar; 268():113556. PubMed ID: 33157223 [TBL] [Abstract][Full Text] [Related]
27. Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis. Li Y; Liu J; Ye B; Cui Y; Geng R; Liu S; Zhang Y; Guo W; Fu S J Agric Food Chem; 2022 Aug; 70(34):10620-10634. PubMed ID: 35973099 [TBL] [Abstract][Full Text] [Related]
28. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells. Sharma A; Anand SK; Singh N; Dwivedi UN; Kakkar P Eur J Pharmacol; 2020 Sep; 882():173244. PubMed ID: 32526241 [TBL] [Abstract][Full Text] [Related]
29. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model. Im AR; Kim YH; Lee HW; Song KH J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979 [TBL] [Abstract][Full Text] [Related]
30. Phlorizin from Lithocarpus litseifolius [Hance] Chun ameliorates FFA-induced insulin resistance by regulating AMPK/PI3K/AKT signaling pathway. Zhao H; Zhai BW; Zhang MY; Huang H; Zhu HL; Yang H; Ni HY; Fu YJ Phytomedicine; 2024 Jul; 130():155743. PubMed ID: 38824822 [TBL] [Abstract][Full Text] [Related]
31. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
32. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091 [TBL] [Abstract][Full Text] [Related]
33. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway. Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897 [TBL] [Abstract][Full Text] [Related]
34. DhHP-6 ameliorates hepatic oxidative stress and insulin resistance in type 2 diabetes mellitus through the PI3K/AKT and AMPK pathway. Wang K; Liang Y; Su Y; Wang L Biochem J; 2020 Jun; 477(12):2363-2381. PubMed ID: 32510127 [TBL] [Abstract][Full Text] [Related]
35. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. Chen JW; Kong ZL; Tsai ML; Lo CY; Ho CT; Lai CS J Food Drug Anal; 2018 Jul; 26(3):1075-1085. PubMed ID: 29976400 [TBL] [Abstract][Full Text] [Related]
36. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392 [TBL] [Abstract][Full Text] [Related]
37. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396 [TBL] [Abstract][Full Text] [Related]
38. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling. Han H; Li X; Guo Y; Zheng M; Xue T; Wang L Food Funct; 2021 Mar; 12(5):2171-2188. PubMed ID: 33566044 [TBL] [Abstract][Full Text] [Related]
39. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis. Li J; Xie S; Teng W Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950 [TBL] [Abstract][Full Text] [Related]
40. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis. Patel TP; Rawal K; Soni S; Gupta S Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]